9 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp06771 | Moricin | AKIPIKAAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKA | Bombyx mori | Peptide-induced cell death | MTT assay | MDA-MB-231 | Triple-negative Breast Cancer | 70% cell viability at 6.25 µg/ml |
| dbacp06772 | Moricin | AKIPIKAAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKA | Bombyx mori | Peptide-induced cell death | LDH release assay | MDA-MB-231 | Triple-negative Breast Cancer | Significant decrease in cell viability at 6.25 μg/ml |
| dbacp06773 | Moricin | AKIPIKAAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKA | Bombyx mori | Peptide-induced cell death | Trypan blue assay | MDA-MB-231 | Triple-negative Breast Cancer | 70% cell viability at 6.25 µg/ml |
| dbacp07931 | myristoyl-CM4 | GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI | Bombyx mori | Cell penetration, Mitochondrial dysfunction, Apoptosis pathway activation | MTT assay | MCF-7 | Breast cancer | IC50 = 6 μM |
| dbacp07932 | myristoyl-CM4 | GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI | Bombyx mori | Enhanced binding, mitochondrial dysfunction, apoptosis | MTT assay | MDA-MB-231 | Breast cancer | IC50 = 4 μM |
| dbacp07933 | myristoyl-CM4 | GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI | Bombyx mori | Enhanced binding, mitochondrial dysfunction, apoptosis | MTT assay | MX-1 | Breast cancer | IC50 = 3 μM |
| dbacp08167 | Bmattacin2 | Not Available | silkworm Bombyx mori | Not Available | MTS assay | A-375 | Skin Cancer | IC50 = 5.23 μM |
| dbacp08168 | Bmattacin2 | Not Available | silkworm Bombyx mori | Not Available | MTS assay | HCT-116 | Colorectal Cancer | IC50 = 1.70 μM |
| dbacp08253 | Cecropin XJ | APEPRWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | Larvae of Bombyx mori | CecropinXJ induces apoptosis in HCC | MTT assay | Huh-7 | Liver Cancer | Cell viability = 50% at 50 µmol/l |